Lancôme, the L’Oréal-owned luxury brand, is aiming to further secure its position as a leader in the longevity beauty game through the launch of a new skin care range.
The yet-to-be-named collection is centred on Swiss biotech firm Timeline’s Mitopure technology, a proprietary molecule backed by more than US$50m in R&D and 15 years of research.
The ingredient is a highly pure form of Urolithin A, a postbiotic that is said to be clinically proven to re-energise mitochondria – the powerhouses of the cell – through a cellular renewal process known as mitophagy – the removal of damaged mitochondria.
It marks L’Oréal Groupe’s first consumer launch with Timeline, following the French beauty giant's investment in the firm in 2024 through a CHF56 million Series D funding round.
The range will be revealed and launched at the annual American Academy of Dermatology (AAD) convention in Denver, Colorado, from 27 - 29 March 2026.
Mitropure has been most commonly used in Timeline’s longevity supplements, but the new skin care line will combine the molecule with Lancôme’s proprietary compounds to deliver longevity benefits via the skin itself.
Unpacking Mitopure and its longevity benefits
Each product in the range has been designed to address the skin's visible biological age – the measure of the actual physiological condition and maturity of skin cells – and is Mitopure’s first deployment at a global scale through a major beauty brand.
And it is this scale, and how it “translates longevity science into sensorial luxury formulas designed for everyday use”, that will help the range stand out in the longevity arena, Vania Lacascade, Global Brand President of Lancôme, told Cosmetics Business.
“This is not just about launching a product, it is about giving women the ability to actively impact their skin’s biological age and closing the gap between what happens in the lab and what happens in women’s daily lives,” said Lacascade.
Delving deeper into the benefits of Mitopure, Lacascade said Lancôme worked to adapt the powerful longevity molecule — originally developed in a nutritional context — into highly performing topical skin care.
Vania Lacascade, Global Brand President of Lancôme
Essentially, Mitopure acts as a “cellular reboot”, helping cells to clean up and recharge.
The range’s development meant considering and respecting the specific biology of the skin, cosmetic regulations, and safety standards at a worldwide level.
However, Lancôme did not settle on simply integrating Mitropure as an ingredient, and instead developed proprietary formulas, delivery systems, and synergistic complexes.
This enables Mitopure to work in synergy with Lancôme’s proprietary compounds, designed specifically for the biology of the skin.
Lacascade continued: “We have built a complete skin care system, where Mitopure works in synergy with our proprietary compounds, designed specifically for the biology of the skin.
“Timeline brings the longevity molecule. Lancôme brings the skin care authority and expertise, the patents, the data, and the deep scientific understanding of skin.”
From supplements, to skin care, to consumer hands
The new skin care builds on Lancôme's previous longevity launch, the PDRN-inspired Absolue Longevity The Soft Cream in 2025
For Lancôme, longevity is not a slogan or a trend, and the partnership with Timeline represents a “new era of innovation” for the brand, said Lacascade.
She continued: “We are moving from reactive correction to proactive and data-driven care – a scientific approach that acts at the root of the mechanisms of ageing.”
But what does this all mean for the regular consumer, who may be unsure about the benefits, differences, and science of Mitopure in its new format?
“Supplements and skin care serve different purposes and work through different routes,” explained Lacascade.
“Timeline has expertise in Mitopure as a longevity molecule, initially formulated for nutritional supplements.
“Lancôme’s role is different: we apply our expertise in skin biology, formulation science, and safety to translate this molecule into topical skin care, adapted to the skin’s biology and cosmetic regulations.”
And while both brands work with Mitopure, the formulations and the approach are different.
Longevity is a science-led commitment for us, not a trend
Lacascade continued: “Lancôme integrates Mitopure within formulas that also include Lancôme’s own proprietary compounds, and proprietary delivery systems developed through our long-standing expertise in skin biology and formulation science.”
When it comes to reassuring the consumer, Lacascade said the brand’s “credibility is built on data”, as Lancôme is keenly focused on scientific validation, patents, and clinical evidence.
“The key difference lies in how we approach ageing itself,” Lacascade added.
“Longevity focuses on supporting skin health throughout every stage of a woman’s journey.
“It is no longer about accepting age or simply correcting visible signs, but about acting on fundamental biological processes to preserve and restore skin health span.
“For Lancôme, longevity is a frontier of radical scientific progress that will shape the future of beauty, fully aligned with what women want today: to live better, not just longer."
This acute focus on science is why Lancôme is choosing to reveal the full details of the launch at the AAD in March.
“At Lancome, we’ve always been a powerhouse of progress,” said Lacascade.
“And what better place to launch our new skin care range that is translating scientific progress into daily longevity beauty products, combining real scientific breakthroughs with high sensorial, luxury skin care?
“After 15 years, Lancôme’s return to AAD signals that longevity is a science-led commitment for us, not a trend.”
Lancôme’s longevity-filled future
L’Oréal’s Cell BioPrint device
Lancôme’s upcoming skin care line builds on L’Oréal Groupe’s Longevity Integrative Science research, which shifts focus from symptom correction to root cause intervention.
To facilitate this, L’Oréal created the ‘Wheel of Longevity for Beauty’ to decode skin ageing at the cellular, molecular, and tissular levels.
This is powered by the French beauty giant’s artificial intelligence-powered (AI) Longevity AI Cloud technology, which decodes skin ageing using the nine interconnected hallmarks of ageing.
It achieves this by analysing more than 260 skin longevity biomarkers, revealing the intricate mechanisms influencing skin vitality and youthfulness, even detecting infinitely small, invisible changes.
Lancôme has stood at the forefront of this increasing investment in longevity science, having launched its PDRN-inspired Absolue Longevity The Soft Cream in 2025.
The Soft Cream uses a patented rose-derived longevity molecule to act on the mitochondria of the skin to intervene and fight off the signs of ageing before they occur.
This was complemented by L’Oréal’s Cell BioPrint device – a new in-store diagnostic tool that can identify biomarkers of ageing specific to the user’s skin.
Developed in partnership with the Korean startup NanoEnTek, this first-of-its-kind “lab-on-chip” solution analyses skin surface biological age and model ageing trajectories.
The upcoming Mitropure-infused skin care range is the latest step in Lancôme’s long-term commitment towards longevity.
“The forthcoming Lancôme range represents a new radical scientific shift for us. The ambition is not just visible results, but to help skin behave in a more youthful, resilient way over time,” said Lacascade.
And going forward, consumers can expect a series of longevity-led innovations, expanding into a complete avant-garde ecosystem.
Lacascade concluded: “But it goes beyond for us. It is also a cultural, almost philosophical challenge, that transcends care and beauty.
“It questions our relationship with age and the taboos that still persist today.
“And as a leader, Lancôme’s role is clear: to pave the way and set in motion a new culture of longevity. Today is just the beginning.”
Readers following advances in skin care science may want to look ahead to the Anti-Ageing Skin Care Conference, returning 23–24 June 2026 in London. It’s a key meeting for experts exploring the future of skin health and ageing. Find out more HERE.
Related content:
- L'Oréal's masterplan to take longevity beauty mainstream
- Vichy’s longevity science play addresses hair loss and zombie cells
- Exclusive: L’Oréal enters nutricosmetics with Vichy’s first collagen supplement
- Inside Lancôme’s strategy to become a frontrunner in longevity beauty
- L'Oréal's masterplan to take longevity beauty mainstream
- L’Oréal CEO says beauty’s future lies in a ‘new era of longevity’, and he plans to democratise it
- La Roche-Posay’s game plan to rule dermo-cosmetics and make €3 billion this year
- Snail Mucin is out: TikTok-famous PDRN is the new skin care hero
